What's new for people with ATM, CHEK2 or PALB2 mutations?

Learn about the cancer risks associated with an ATM, CHEK2 or PALB2 mutation and the risk-management options for people with an inherited mutation in one of these genes. Presented by Tuya Pal, MD; Marc Tischkowitz, MD, PhD. Learn more about genetic testing and hereditary cancer:

Our mission is to improve the lives of individuals and families facing hereditary cancer.

Sign up to stay in-the-know about hereditary cancer https://www.facingourrisk.org/subscribe

FORCE website

  / facingourrisk  

FORCE on Facebook  FORCE: Facing Our Risk of Cancer Empowered   / facingourrisk  

FORCE on Instagram facingourrisk

https://www.linkedin.com/company/forc...

FORCE on LinkedIn  FORCE: Facing Our Risk of Cancer Empowered

https://www.linkedin.com/company/forc...

FORCE on Twitter  @FacingOurRisk

https://twitter.com/FacingOurRisk?ref...